Professor Amy Berrington’s team is investigating the late-effects of cancer treatments, medical radiation exposures and other medications to improve outcomes for patients.
Professor Amy Berrington is an expert in the use of real world data to study the late-effects of cancer treatments, medical radiation exposures and other medications and is leading major studies in this field in breast and childhood cancer survivors. She is a member of multiple national and international advisory boards and is currently Vice-Chair of the US National Academy of Science Nuclear and Radiation Studies Board.
Dr Michael Jones is a senior staff scientist in the Division of Genetics and Epidemiology, where he is working on the Breast Cancer Now Generations Study. His main research interests are in the design and analysis of complex large epidemiological studies.